BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 31689414)

  • 1. Six-Minute Walk Test: Clinical Role, Technique, Coding, and Reimbursement.
    Agarwala P; Salzman SH
    Chest; 2020 Mar; 157(3):603-611. PubMed ID: 31689414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 6-min walk test: clinical and research role, technique, coding, and reimbursement.
    Salzman SH
    Chest; 2009 May; 135(5):1345-1352. PubMed ID: 19420202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short- and Long-Term Reliability of the 6-Minute Walk Test in People With Idiopathic Pulmonary Fibrosis.
    Holland AE; Hill CJ; Dowman L; Glaspole I; Goh N; Lee AL; McDonald CF
    Respir Care; 2018 Aug; 63(8):994-1001. PubMed ID: 29945909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The six-minute walk test in sarcoidosis associated pulmonary hypertension: Results from an international registry.
    Gupta R; Baughman RP; Nathan SD; Wells AU; Kouranos V; Alhamad EH; Culver DA; Barney J; Carmona EM; Cordova FC; Huitema M; Scholand MB; Wijsenbeek M; Ganesh S; Birring SS; Price LC; Wort SJ; Shlobin OA
    Respir Med; 2022 May; 196():106801. PubMed ID: 35316723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic ability of the distance-saturation product in the 6-minute walk test in patients with chronic obstructive pulmonary disease.
    Gurbani N; Figueira Gonçalves JM; García Bello MÁ; García-Talavera I; Afonso Díaz A
    Clin Respir J; 2020 Apr; 14(4):364-369. PubMed ID: 31883431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors in routine practice of 6-min walking distance and oxygen desaturation in patients with COPD: impact of comorbidities.
    Perez T; Deslée G; Burgel PR; Caillaud D; Le Rouzic O; Zysman M; Escamilla R; Jebrak G; Chanez P; Court-Fortune I; Brinchault-Rabin G; Nesme-Meyer P; Paillasseur JL; Roche N;
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1399-1410. PubMed ID: 31308646
    [No Abstract]   [Full Text] [Related]  

  • 7. Alternative Indexes to Estimate the Functional Capacity From the 6-Minute Walk Test in Children and Adolescents With Cystic Fibrosis.
    Okuro RT; de Oliveira Ribeiro MA; Ribeiro JD; Minsky RC; Schivinski CI
    Respir Care; 2017 Mar; 62(3):324-332. PubMed ID: 28049743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise hypoxaemia as a predictor of pulmonary hypertension in COPD patients without severe resting hypoxaemia.
    Nakahara Y; Taniguchi H; Kimura T; Kondoh Y; Arizono S; Nishimura K; Sakamoto K; Ito S; Ando M; Hasegawa Y
    Respirology; 2017 Jan; 22(1):120-125. PubMed ID: 27471142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-Person Versus Remote 6-Minute Walk and Incremental Shuttle Walk Distances in Advanced Lung Disease.
    Wickerson LM; de Paula Ferreira M; Rozenberg D; Mathur S; Singer LG
    Respir Care; 2024 Apr; 69(5):557-565. PubMed ID: 38649272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gas exchange responses during 6-min walk test in patients with pulmonary arterial hypertension.
    Morris NR; Seale H; Harris J; Hall K; Lin AC; Kermeen F
    Respirology; 2017 Jan; 22(1):165-171. PubMed ID: 27530086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distance and oxygen desaturation during the 6-min walk test as predictors of long-term mortality in patients with COPD.
    Casanova C; Cote C; Marin JM; Pinto-Plata V; de Torres JP; Aguirre-Jaíme A; Vassaux C; Celli BR
    Chest; 2008 Oct; 134(4):746-752. PubMed ID: 18625667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of the desaturation-distance ratio from the six-minute walk test for patients with COPD.
    Fujimoto Y; Oki Y; Kaneko M; Sakai H; Misu S; Yamaguchi T; Mitani Y; Yasuda H; Ishikawa A
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2669-2675. PubMed ID: 28919734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 1-Minute Sit-to-Stand Test in Adults With Cystic Fibrosis: Correlations With Cardiopulmonary Exercise Test, 6-Minute Walk Test, and Quadriceps Strength.
    Gruet M; Peyré-Tartaruga LA; Mely L; Vallier JM
    Respir Care; 2016 Dec; 61(12):1620-1628. PubMed ID: 27899540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of walk distance, work, oxygen saturation, and dyspnea during 6-minute walk test in COPD patients.
    Golpe R; Pérez-de-Llano LA; Méndez-Marote L; Veres-Racamonde A
    Respir Care; 2013 Aug; 58(8):1329-34. PubMed ID: 23322886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of a new parameter in the 6-minute walk test for manifold analysis of exercise capacity in patients with COPD.
    Ijiri N; Kanazawa H; Yoshikawa T; Hirata K
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1235-40. PubMed ID: 25395845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Six minute walk test versus incremental shuttle walk test in cystic fibrosis.
    Saglam M; Vardar-Yagli N; Savci S; Inal-Ince D; Aribas Z; Bosnak-Guclu M; Arikan H; Calik-Kutukcu E; Gunes-Yalcin E
    Pediatr Int; 2016 Sep; 58(9):887-93. PubMed ID: 26756566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One Year Change in 6-Minute Walk Test Outcomes is Associated with COPD Prognosis.
    Waatevik M; Frisk B; Real FG; Hardie JA; Bakke P; Nilsen RM; Eagan TM; Johannessen A
    COPD; 2020 Dec; 17(6):662-671. PubMed ID: 33164586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 6-minute walk work for assessment of functional capacity in patients with COPD.
    Carter R; Holiday DB; Nwasuruba C; Stocks J; Grothues C; Tiep B
    Chest; 2003 May; 123(5):1408-15. PubMed ID: 12740255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Six-minute walking test in cystic fibrosis adults with mild to moderate lung disease: comparison to healthy subjects.
    Chetta A; Pisi G; Zanini A; Foresi A; Grzincich GL; Aiello M; Battistini A; Olivieri D
    Respir Med; 2001 Dec; 95(12):986-91. PubMed ID: 11778797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standardization of the 6-min walk test in clinical trials of idiopathic pulmonary fibrosis.
    Lancaster L; Fieuw A; Meulemans J; Ford P; Nathan SD
    Contemp Clin Trials; 2021 Jan; 100():106227. PubMed ID: 33246099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.